HERM Seminar series

19 January

Title: Thread of excess: RNA control of metabolite fate

• Speaker: Claudia Kutter, Principal Researcher, Department of Microbiology, Tumor and Cell Biology, KI.
   
• Host: Sören Lehmann, HERM, MedH, KI.

26 January

Title: Pain neurons control cancer immunosurveillance

• Speaker: Sébastien Talbot, Principal Researcher, Department of Physiology and Pharmacology, KI.
   
• Host: Nicole Marquardt, HERM, MedH, KI.

9 February

HERM seminar series - “Tissue-Resident Memory T Cells: Adaptation, Plasticity, and Therapeutic Implications"

• Speaker: Thomas Müller, Assistant Professor, HERM, MedH, KI.
   
• Host: Yenan Bryceson, HERM, MedH, KI.

12 February, 15:00-16:00

Title: Genetic diversity of congenital neutropenia: Implications for malignant transformation to MDS/AML

• Speaker: Professor Ivo Touw, Erasmus MC, the Netherlands.
   
• Host: Eva Hellström Lindberg, HERM, MedH, KI.

16 February

Title: High‑throughput approaches for evaluating functional consequences of disease‑associated genetic variants and programming proteome–epigenome interactions

• Speaker: Karl Carlström, Assistant Professor, Department of Laboratory Medicine, KI.
   
• Host: Yenan Bryceson, HERM, MedH, KI.

2 March

Tilte: Type 2 Immunity Holds Key to Cancer Cure? The Journey from Bench to Bedside and Back

• Speaker: Li Tang
  Associate Professor, Institute of Bioengineering (IBI) / Institute of Materials Science & Engineering (IMX) / Vice Dean for Innovation, School of Life Sciences, École polytechnique fédérale de Lausanne (EPFL)
• Host: Yenan Bryceson, HERM, MedH, KI.

9 March

Title: Signal integration in cytotoxic lymphocytes during infection

• Speaker: Simon Grassman, M.D., Immunology Program, Memorial Sloan Kettering Cancer Center, USA
   
• Host: Thomas Müller, HERM, MedH, KI.

16 March

Title: Precision engineering of cell fates via data-driven multi-gene control of transcriptional networks

• Speaker: Jens Magnusson, Assistant Professor, Department of Laboratory Medicine, KI.
   
• Host: Yenan Bryceson, HERM, MedH, KI.

23 March

Title: Radiopharmaceuticals and their anti-tumor immunity

• Speaker: Zhibo Liu, Professor and Chair of Applied Chemistry, Peking University. Leading scientist at Changping Laboratory, China. 
   
• Host: Hong Qian, HERM, MedH, KI.

30 March

Title: Interplay of clonal landscape and its remodeling in MDS and MPN undergoing transplantation

• Speaker: Nico Gagelmann, MD, PhD, Dana Farber Cancer Institute, Boston, MA and University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
   
• Host: Magnus Tobiasson, HERM, MedH, KI.

13 April

Title: Group 2 innate lymphoid cells in the regulation of normal and malignant hematopoiesis

• Speaker: Sergio Martinez-Høyer, Division of Virology and Immunology, Department of Microbiology, Tumor and Cell Biology, KI.
   
• Host: Andreas Lennartsson, HERM, MedH, KI.

27 April

Title: Tissue-resident memory T cells in autoimmune rheumatic diseases

• Speaker: Karine Chemin, Docent, CMM, MedS, KI.
   
• Host: Isabelle Magalhaes, HERM, MedH, KI.

18 May

Title: Inducing tumor-specific T cell responses in absence  of CD28 ligands and immune-checkpoint inhibitors

• Speaker: Bernard Malissen, Centre d'Immunologie de Marseille Luminy (CIML).
   
• Host: Yenan Bryceson, HERM, MedH, KI.

25 May

Title: CAR T-cell therapy at Karolinska: Current status and future developments

• Speaker: Stephan Mielke, Professor, Department of Laboartory Medicine, KI
  Center for Allogen Stemcell Transplantation (CAST), Karolinska University hospital Huddinge
  Director of the Cellular Therapy and Allogeneic Stem Cell Transplantation Program (JACIE)
  Member of Board of Directors of Karolinska Comprehensive Cancer Center (OECI) and Karolinska ATMP Center Karolinska Institutet and University Hospital
   
• Host: Magnus Tobiasson, HERM, MedH, KI.

26 May

Title: Arrested development: cell dynamics in human NK cell differentiation

• Speaker: Emily Mace, Department of Paediatrics, Columbia University Medical Center, New York, USA
   
• Host: Tessa Campbell, HERM, MedH, KI.

1 June

Title: How T-cells cure cancer: Lessons from successful immunotherapy?

• Speaker: Professor Andrew Sewell, Distinguished Research Professor and Wellcome Trust Senior Investigator; Division of Infection and Immunity Cardiff University School of Medicine; Visiting Professor, Kumamoto University.
   
• Host: Antonino Cassotta, HERM, MedH, KI.

1 September

Title: Improving TIL therapy through combination with a DC tumor vaccine or protection of T cells against damaging oxidative stress

• Speaker: Stina Wickström, Docent, Department of Oncology-Pathology, KI.
   
• Host: Arnika Wagner, HERM, MedH, KI.

8 September

Title: Targeting Epigenetic and transcriptional vulnerabilities in AML for cure and diagnostics

• Speaker: Andreas Lennartsson, HERM, Department of Medicine, Huddinge (MedH), KI.
   
• Host: Nicole Marquardt, HERM, MedH, KI.

15 September

Title: Development of stem cell-based therapies for blindness and type-1 diabetes

• Speaker: Fredrik Lanner, Department of Clinical Science, Intervention and Technology, KI. 
   
• Host: Nicole Marquardt, HERM, MedH, KI.

25 September 

Title: Expanding CAR T Access: Overcoming Implementation Barriers and Exploring γδ T Innovations

• Speaker: Jürgen Kuball, Department of Hematology at the UMC Utrecht Cancer Centre, Netherlands.
   
• Host: Michael Uhlin, HERM, MedH, KI.
   
• Time: 16:00-17:00

29 September 

Title: Interrogating Immunosuppressive Niches of Colon Cancer Stem Cells Using Spatial Transcriptomics

• Speaker: Xi He, Stowers Institute for Medical Research, Kansas City, USA.
   
• Host: Hong Qian, HERM, MedH, KI.
   
• Time: 12:00-13:00.

29 September 

Title: A track of the clones: Understanding haematopoietic stem cell identity and function at the single cell level

• Speaker: David Kent, Centre for Blood Research, York Biomedical Research Institute, York, UK.
   
• Host: Petter Woll, HERM, MedH, KI.
   
• Time: 15:30-16:30

30 September

KI South distinguished lecture: Microenvironmental regulation of normal and cancerous stem cells

• Speaker: Linheng Li, Stowers Institute for Medical Research, Kansas City, USA.
   
• Location: Jan-Åke Gustafssonsalen in Neo.
   
• Time: 15:00-16:00.
   
• Host: Hong Qian, HERM, MedH, KI.

6 October

Title: The developmental origins and pathogenesis of infant leukaemia

• Speaker: Professor Katrin Ottersbach, Centre for Regenerative Medicine, Institute for Regeneration and Repair, University of Edinburgh, UK.
   
• Host: Hong Qian, HERM, MedH, KI.

13 October

Title: NK cells in host immunity

• Speaker: Joseph Sun, Memorial Sloan Kettering Cancer Center, USA.
   
• Host: Yenan Bryceson, HERM, MedH, KI.

20 October

Title: Local and distal renewal of Trm cells in healthy and diseased human skin

• Speaker: Liv Eidsmo, CMM, Department of Medicine, Solna, KI.
   
• Host: Nicole Marquardt, HERM, MedH, KI.

10 November

Title: Functional and Molecular Determinants of Venetoclax Response and Resistance in Acute Myeloid Leukemia

• Speaker: Mika Kontro.
   
• Host: Martin Jädersten, HERM, MedH, KI.

12 November at 14:00-15:00

Title: Somatic mutations and rheumatic disease

• Speaker: David Beck, Assistant Professor, New York University Grossman School of Medicine.
   
• Host: Eva Hellström Lindberg, HERM, MedH, KI.

17 November

Title: LRP8 is a receptor for Tick-borne encephalitis virus

• Speaker: Sara Gredmark Russ, CIM, MedH, KI.
   
• Host: Nicole Marquardt, HERM, MedH, KI.

27 November at 15:00-16:00

Title: How to do research in a blood bank close to the arctic circle: Metabolomics, pathogen reduction and cold storage

• Speaker: Ólafur Eysteinn Sigurjónsson, Vice President for Research, Innovation & Industry Relations at Reykjavík University and Director of R&D at the Landspítali Blood Bank, Iceland.
   
• Host: Agneta Wikman, HERM, MedH, KI.

15 December

Title: Clonal hematopoiesis: Insights from inflammation and solid tumors

• Speaker: Mikko Myllymäki, MD, PhD, University of Helsinki, Finland.
   
• Host: Pedro Moura, HERM, MedH, KI.